Filing Flows › Kopin (KOPN) › Q1 2026 › vs Q1 2025
Kopin (KOPN) Q1 2026 vs Q1 2025 (year over year)
Kopin's revenue rose $13K (+0.1%) from $10.5M in Q1 2025 to $10.6M in Q1 2026. The biggest changes: Research and Development Revenues +$54K (+4%); Research and Development +$54K (+4%); License and Other Revenues −$7K (-10%).
Kopin, Q1 2026: revenue $10.6M (+0.1% year over year), operating margin -56.7%, net loss $3.8M, operating cash flow −$811K. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Research and Development Revenues | $1.3M | $1.2M | $54K | +4% |
| Research and Development | $1.3M | $1.2M | $54K | +4% |
| License and Other Revenues | $65K | $72K | −$7K | -10% |
| License and Royalties | $65K | $72K | −$7K | -10% |
| Revenue | $10.6M | $10.5M | $13K | +0.1% |
| Other income, net | $2.3M | $846K | $1.4M | +171% |
| Net loss | $3.8M | $3.1M | $639K | +21% |
| Costs & expenses | $16.6M | $14.5M | $2.1M | +14% |
| Operating costs | $16.5M | $14.4M | $2.1M | +14% |
| Income tax | $57K | $52K | $5K | +10% |
| Research & development | $1.1M | $1.5M | −$372K | -25% |
| SG&A | $6.0M | $4.7M | $1.3M | +28% |
| Other operating costs | $9.4M | $8.3M | $1.1M | +14% |
| Operating cash sources | $3.8M | $3.1M | $639K | +21% |
| Depreciation & amortization | $247K | $220K | $28K | +13% |
| Share-based compensation | $495K | $774K | −$279K | -36% |
| Working capital & other | $2.2M | −$1.3M | $3.5M | — |
| Cash used in operations | $811K | $3.4M | −$2.6M | -76% |
| Net loss absorbed | $3.8M | $3.1M | $639K | +21% |
Questions
How much did Kopin's revenue grow year over year in Q1 2026?
Kopin's revenue rose $13K (+0.1%) from $10.5M in Q1 2025 to $10.6M in Q1 2026.
What drove Kopin's revenue change in Q1 2026?
Research and Development Revenues +$54K (+4%); Research and Development +$54K (+4%); License and Other Revenues −$7K (-10%).